This website uses cookies
Read our Privacy policy and Terms of use for more information.
Nov 4, 2026
•
3 min read
Open enrollment opens November 1. Four point six million people already left the individual market while the field argued about drug prices.
Oct 28, 2026
4 min read
Medicare open enrollment opens October 15. CMS made plan level prior authorization data public in March, and the advocacy field left it on the shelf.
Oct 21, 2026
CMS cancelled coverage for more than 760,000 people six weeks before Open Enrollment and published no way for any of them to find out or fight back.
Oct 14, 2026
Four PBMs now hold 75 percent of the market, and every one of the ten largest shares an owner with a health insurer. Patients pay for that structure at the counter.
Oct 7, 2026
11 min read
September rewarded everyone with a seat at the table. Drugmakers traded concessions for exemptions, arbiters collected a fee per dispute, and vendors earned a cut of every denied claim. Patients got a letter, a bill, or a paperwork deadline.
Oct 28, 2025
7 min read
Just imagine if a fraction of the advertising budget went to patient advocacy!
Oct 21, 2025
The Health System Must Do More For Patients
Oct 14, 2025
5 min read
AZ & Pfizer have already been to the White House. Many more are expected to do the same. But this does nothing for patients today...
Oct 7, 2025
6 min read
This month, we expose the disconnect between policy promises and patient realities—across systems, sectors, and strategies.
Sep 5, 2025
From Policy to Patients: Confronting the Shifts That Will Define Healthcare This Fall
Aug 27, 2025
Advocacy leaders rank J&J Innovative Medicines, Otsuka, Neurocrine, and BMS at the top—while calling out gaps in access, affordability, and equity
Aug 4, 2025
Resetting the Stage for Real Change
Jul 8, 2025
Inside the July Pulse: Policy showdowns, equity gaps, tech letdowns, and the real cost of staying silent.
Jun 12, 2025
Unveiling the Data. Elevating the Voice. Fueling a New Era of Patient-Centered Leadership
